Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

In the published article[1][1], the affiliation for the first author, Xingsheng Hu, is “Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences”, we would like to update it to “Department of Medical Oncology, National Cancer Center/National Clinical Research Center

Abstract licence: CC BY-NC

1. 9.

   BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells · 2003

2. 23.

   Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories · 2017

27 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.